Ruben Amarasingham, MD
About Ruben Amarasingham, MD
Ruben Amarasingham, MD, is the Founder and CEO of Pieces Technologies, Inc., a healthcare AI research and development firm based in the Dallas/Fort Worth area since 2016. He has a diverse background in medicine and healthcare leadership, with extensive experience in integrating AI technologies to improve healthcare efficiency.
Work at Pieces
Ruben Amarasingham serves as the Founder and CEO of Pieces Technologies, Inc., a healthcare AI research and development firm based in the Dallas/Fort Worth area. Since founding the company in 2016, he has focused on integrating artificial intelligence technologies to enhance the efficiency of healthcare professionals. Under his leadership, Pieces has developed innovative solutions aimed at supporting doctors and nurses in their daily work. Amarasingham is scheduled to speak at the upcoming Pieces Clinical Generative AI Symposium in 2024, highlighting his commitment to advancing healthcare through technology.
Education and Expertise
Ruben Amarasingham holds a Doctor of Medicine (MD) degree from UT Southwestern Medical Center, where he completed his residency in Internal Medicine from 1995 to 2002. He also earned a Master of Business Administration (MBA) from The Johns Hopkins University - Carey Business School, studying from 2003 to 2006. Additionally, he obtained a ScB in Neuroscience and English Literature from Brown University between 1991 and 1995. His educational background supports his expertise in both medicine and business, allowing him to effectively lead a healthcare technology firm.
Background
Ruben Amarasingham's professional journey includes significant roles in various healthcare organizations. He co-founded St. Andrew's School and served as Commissioner of SAISL from 1988 to 1991. He worked at Parkland Hospital in multiple capacities, including Associate Chief of Medicine and Medical Director of Medical Services, from 2006 to 2013. He also held the position of Associate Professor at UT Southwestern, contributing to the Department of Internal Medicine and Department of Clinical Sciences from 2006 to 2016. His experience extends to serving on the National Board of Directors for HIMSS from 2016 to 2019.
Achievements
Ruben Amarasingham has made notable contributions to the field of healthcare technology. He has been instrumental in the integration of AI technologies at Pieces Technologies, enhancing the work of healthcare professionals. His leadership has positioned Pieces as a key player in healthcare AI research and development. Amarasingham's involvement in various organizations, including his role as President and CEO at PCCI from 2013 to 2017, reflects his commitment to improving healthcare delivery through innovative solutions.